Gene · 5142
Papers1,785
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,785
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP-PKA-RhoA pathway. | RMD Open | 2026 | 42097695 | PubTator, text mining | PubMed |
| Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis. | Front Med (Lausanne) | 2026 | 42094953 | PubTator, text mining | PubMed |
| Pde4 mediates MHCII expression in oligodendroglia. | Proc Natl Acad Sci U S A | 2026 | 42085152 | PubTator, text mining | PubMed |
| Conserved Cell-Type-Specific Transcriptomic Networks and Regulatory Programs Underlie Alcohol Dependence Across Mouse and Human. | Res Sq | 2026 | 42078895 | PubTator, text mining | PubMed |
| Circulating Biomarkers for Predicting Disease Progression in Idiopathic Pulmonary Fibrosis: Insights into Precision Medicine. | Lung | 2026 | 42045697 | PubTator, text mining | PubMed |
| Transdermal self-assembled Xanthine/hybrid needle nanofibers for management of abdominal obesity via phosphodiesterase 4B suppression. | Mol Divers | 2026 | 41961395 | PubTator, text mining | PubMed |
| Immunological mechanisms and therapeutic approaches in pulmonary fibrosis. | Eur Respir Rev | 2026 | 41951242 | PubTator, text mining | PubMed |
| Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth. | Cancer Res Commun | 2026 | 41937294 | PubTator, text mining | PubMed |
| 3-Aminoisoquinolines inhibit selectively phosphodiesterase 4B in KRAS-mutated colorectal cancer cell lines in-vitro and in-vivo. | Anticancer Drugs | 2026 | 41934673 | PubTator, text mining | PubMed |
| Treatable traits in interstitial lung disease: towards precision medicine. | Thorax | 2026 | 41932834 | PubTator, text mining | PubMed |
| Integrating Network Pharmacology, Molecular Dynamics, Machine Learning, and Animal Experiments to Decipher the Anti-fibrotic Mechanism of BI 1015550 in Idiopathic Pulmonary Fibrosis. | Curr Comput Aided Drug Des | 2026 | 41926303 | PubTator, text mining | PubMed |
| Pathogenesis and immune regulation of rheumatoid arthritis-associated interstitial lung disease: from basic research to clinical implications. | Front Immunol | 2026 | 41909710 | PubTator, text mining | PubMed |
| Nerandomilast in Autoimmune-Associated Interstitial Lung Diseases: Translating Evidence from Progressive Pulmonary Fibrosis Studies. | J Clin Med | 2026 | 41899090 | PubTator, text mining | PubMed |
| Targeting the epithelium in pulmonary fibrosis. | Eur Respir Rev | 2026 | 41881452 | PubTator, text mining | PubMed |
| [Evolving management of SARD-ILD : Current challenges and emerging treatment options for rheumatoid-associated interstitial lung diseases]. | Z Rheumatol | 2026 | 41879828 | PubTator, text mining | PubMed |
| Targeting autoimmunity: Phosphodiesterase inhibitors as immunomodulators-a review of current insights and future direction. | Autoimmun Rev | 2026 | 41839428 | PubTator, text mining | PubMed |
| Cross-tissue integrative transcriptomic and multimodal analyses suggest shared immune signatures linking lupus nephritis and cutaneous lupus erythematosus. | Front Immunol | 2026 | 41816342 | PubTator, text mining | PubMed |
| Safety and Efficacy of Nerandomilast in Patients With Pulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Clin Respir J | 2026 | 41810560 | PubTator, text mining | PubMed |
| Network meta-analysis of pharmacological treatments for idiopathic pulmonary fibrosis: evaluating effects on lung function. | Front Pharmacol | 2026 | 41808863 | PubTator, text mining | PubMed |
| Integrated Biochemical and Cellular Validation of SIP0401 as an Isoform-preferential PDE4B Inhibitor. | Mol Biol Rep | 2026 | 41806218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5142/papers?page=2